Pacira BioSciences' Inventory Average rose 4205.24% to $152.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.9 million, marking a year-over-year increase of 4205.24%. This contributed to the annual value of $114.8 million for FY2024, which is 1457.92% up from last year.
Per Pacira BioSciences' latest filing, its Inventory Average stood at $152.9 million for Q3 2025, which was up 4205.24% from $141.0 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Inventory Average ranged from a high of $152.9 million in Q3 2025 and a low of $64.6 million during Q1 2021
Over the past 5 years, Pacira BioSciences' median Inventory Average value was $100.1 million (recorded in 2024), while the average stood at $100.5 million.
Per our database at Business Quant, Pacira BioSciences' Inventory Average surged by 5727.27% in 2022 and then tumbled by 937.23% in 2023.
Quarter analysis of 5 years shows Pacira BioSciences' Inventory Average stood at $82.9 million in 2021, then rose by 16.35% to $96.4 million in 2022, then rose by 4.15% to $100.4 million in 2023, then increased by 18.06% to $118.6 million in 2024, then rose by 28.97% to $152.9 million in 2025.
Its Inventory Average stands at $152.9 million for Q3 2025, versus $141.0 million for Q2 2025 and $129.5 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value